Ferric Citrate Tablet, Film Coated
Product Images NDC 0480-2996

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ferric Citrate (NDC 0480-2996). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1 (Image 1)

Chemical structure of ferric citrate showing the complex coordination of ferric ion (Fe+3) with citrate ligands and water molecules. The structure includes notation for variable stoichiometric coefficients x and y indicating ranges for these components.*

FDA Label Image

1 (Image 2)

A line graph depicting mean serum phosphorus levels (mg/dL) over a 52-week study period comparing Ferric Citrate and an active control. The x-axis shows study time points from baseline to week 52, and the y-axis shows mean serum phosphorus values with error bars at each time point for both treatments.*

FDA Label Image

1 (Image 3)

Ferric Citrate Tablets 210 mg film-coated tablet label by Teva Pharmaceuticals, Inc. The label includes NDC 0480-2996-97 and indicates a bottle of 200 tablets. Storage instructions, warning about overdose, manufacturer information, and a barcode are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.